Laura J. Goldstein
Summary
Driven, innovative leader skilled at shaping strategy in novel and ambiguous spaces, who inspires high-performing teams to collaborate globally and across functions to develop value-based solutions that facilitate market access
Overview
15
15
years of professional experience
Work History
Sr. Director, Global & US Health Economics & Market Access, Joint Reconstruction, Robotics, Digital, and Emerging Channels
DePuy Synthes
11.2020 - Current
- Leads HEMA end-to-end global strategy and US strategy and execution for highest priority growth platforms within the DePuy Synthes organization, building team from one direct report to five
- Drove creation of evidence generation strategy for nascent digital and robotics platform, shaping the strategy to include novel study designs including retrospective data use collaborations, time-driven activity-based costing studies and comparative effectiveness, leading to more than 20 collaborations with key opinion leaders and 15 publications
- Developed high performing team that has and trained hundreds of employees and sales and sales consultants on more than 20 evidence-based studies and tools created by the team and has developed more than 100 new health economic claims to drive market growth and product differentiation
- J&J MedTech co-lead for development of a global digital reimbursement strategy, has helped to shape the environment both in the US and globally to support the use of additional codes to facilitate incremental reimbursement for key products including robotic and navigation technologies
Lead, Global & US Health Economics & Market Access
Biosense Webster
10.2017 - 11.2020
- Lead global HEMA team of four individuals with end-to-end portfolio responsibility, from new product development through commercial execution, responsibilities include ensuring products have distinct value propositions and reimbursement/access strategies, driving global economic evidence strategy, development of evidence and tool dissemination strategy, global health policy, innovative payment models
- Drove strategy and creation of global 'Burden of Disease' strategy, highlighting patient, clinical and economic burden of atrial fibrillation which has resulted in more than 120 media pick ups across 20 countries, reaching more than 5 million people globally
- Partnered with local team and KOLs to drive China reimbursement strategy, which has resulted in a specific code being established for atrial fibrillation ablation, facilitating an expected 34% higher payment for procedures
Associate Director, Global Health Economics & Market Access
Ethicon and Biosense Webster, HEMA COE
11.2015 - 10.2017
- Lead for 20+ member multi-regional, cross-functional team, charged with developing an evidence generation and dissemination strategy for current Biosense Webster portfolio, team generated more than 25 publications, 20 collateral materials
- Therapeutic areas of focus in Ethicon include bariatrics, colorectal and hepatopancreatobiliary, global responsibility to lead current and future specialty strategy by: designing studies (claims databases, EMRs, registries, cost-effectiveness, budget impact), creating collateral materials for sales and strategic customer group use (value briefs/dossiers, VAC packs, interactive models, one page evidence summaries), guiding reimbursement/market access strategy and development of KOL and payer relationships
- Responsible for key markets in Bariatric Game Changer initiative, Game Changer led to 6% procedure growth in targeted countries and provided $12 million in incremental revenue by the end of 2016
Manager, Health Economics & Market Access
Johnson & Johnson Medical Companies Canada
06.2011 - 11.2015
- Developed multi-product hospital acquired infection joint value solution focused on the patient clinical pathway with internal and hospital stakeholders, solution was implemented successfully and was mutually beneficial for internal and external teams, leading $150k in incremental sales and a reduced hospital SSI rate
- Co-lead on cross-functional bariatric surgery market access project targeting an increase in procedure volume in British Columbia, developed strategy and met with key stakeholders including hospital leadership and government officials, causing procedure volume grew more than 20% in 2014
- Developed process to embed Health Economics & Market Access team within the tender response process, created strategy to include clinical and economic information into responses, excellent results including the win of a $1M biosurgery tender where anticipated chance of success was 25%
- Managed both Medical Information and Health Economics associates
Policy Analyst
Baltimore City Office of Emergency Management
01.2010 - 01.2011
- In collaboration with Baltimore city officials developed Baltimore City’s Code Blue Policy, which outlined municipal response to extreme cold weather by conducting research and communicating with key stakeholders in city government and across other municipalities and developed outreach dissemination strategy
Education
Master of Science - Public Health
Johns Hopkins University, Bloomberg School of Public Health
Baltimore, MDJuris Doctor - Law
University of Toronto, Faculty of Law
Toronto, ONHonours Bachelor of Arts - Philosophy
University of Western Ontario
London, ONSkills
- Strategy development to drive market access globally
- Identification of customer needs and development of customer relationships
- Team building and organizational development
- Managing through ambiguous and uncertain environments
- Development of creative solutions to demonstrate the value of products and solutions
Accomplishments
- Developed high-performing team that has trained hundreds of internal and external stakeholders on more than 20 studies and evidence-based tools and developed more than 70 claims to drive sales growth and differentiation
- Drove creation of evidence generation strategy for nascent digital and robotics platform, shaping to include novel study types including data use collaborations, time-driven activity-based costing studies and comparative effectiveness, has led to more than 20 collaborations with key opinion leaders and 15 publications
- Drove strategy and creation of global burden of disease strategy, highlighting patient, clinical and economic burden of atrial fibrillation which has resulted in more than 120 media pick ups across 20 countries, reaching more than 5 million people globally
Education
English
Elementary
Publications
- Cost-effectiveness of catheter ablation versus medical therapy for the treatment of atrial fibrillation in the United Kingdom., Leung, LMW, Imhoff, RJ… Goldstein, L… Gallagher, MM, Journal of cardiovascular electrophysiology, 33, 2, 164-175, 2022, 10.1111/jce.15317
- Predictors of Cardiac Perforation with Catheter Ablation of Atrial Fibrillation., Friedman, DJ, Pokorney SD, Ghanem, A…Goldstein, L, Piccini, JP, Journal of the American College of Cardiology: Electrophysiology, 2020, 10.1016/j.jacep.2020.01.011
- Cost minimization analysis of catheter ablation for paroxysmal atrial fibrillation by catheter technology., Osorio, J, Imhoff, R J, Mallow, PJ, Hunter, TD, Goldstein, L, Rajendra, A, & Morales, G, Journal of comparative effectiveness research, 8, 4, 241-249, 2019
- A cost analysis of early biliary strictures following orthotopic liver transplantation in the United States., Bhutiani, N… Goldstein, LJ…Cannon, RM, Clinical transplantation, 32, 10, e13396, 2018, 10.1111/ctr.13396
Awards
- Selected as one of 25 cross-sector leaders to join the CSS/Vision Care Leadership Forum
- 2017 Johnson & Johnson James E. Burke Award Winner for role in the Evidence Generation and Dissemination strategy leading to market access of bariatric surgery in Brazil
- Winner of 2016 Ethicon Marketing Mastery award in the category of Strategic Innovation & Pipeline Preparation
Timeline
Sr. Director, Global & US Health Economics & Market Access, Joint Reconstruction, Robotics, Digital, and Emerging Channels
DePuy Synthes
11.2020 - Current
Lead, Global & US Health Economics & Market Access
Biosense Webster
10.2017 - 11.2020
Associate Director, Global Health Economics & Market Access
Ethicon and Biosense Webster, HEMA COE
11.2015 - 10.2017
Manager, Health Economics & Market Access
Johnson & Johnson Medical Companies Canada
06.2011 - 11.2015
Policy Analyst
Baltimore City Office of Emergency Management
01.2010 - 01.2011
Honours Bachelor of Arts - Philosophy
University of Western Ontario
Master of Science - Public Health
Johns Hopkins University, Bloomberg School of Public Health
Juris Doctor - Law
University of Toronto, Faculty of Law
Similar Profiles
James CaywoodJames Caywood
Senior Product Designer at DEPUY ORTHOPAEDICS (DEPUY SYNTHES)Senior Product Designer at DEPUY ORTHOPAEDICS (DEPUY SYNTHES)
Jarett UpchurchJarett Upchurch
Territory Sales Manager Foot and Ankle West Region at Depuy SynthesTerritory Sales Manager Foot and Ankle West Region at Depuy Synthes
Ahmed ElsayedAhmed Elsayed
Territory manager at Depuy SynthesTerritory manager at Depuy Synthes